Pharmacokinetics of Oral Hydroxyurea Solution

Clinical trial NCT03763656 · COMPLETED

Trial details

NCT number: NCT03763656
Sponsor: Nova Laboratories Limited
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease Sickle-Cell; Hemoglobin Disease, Thalassemia Sickle Cell-beta-thalassemia Sickle Cell Hemoglobin C

Start date: 2019-01-03
Primary completion: 2021-05-19
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.